Dopamine agonists vs levodopa in impulse control disorders

Archives of Neurology

Volumn 68, Issue 4, 2011, Pages 544-545

  Grosset, Donald G ^a   Cardoso, Francisco ^b   Lees, Andrew ^c  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

CANADA; DISEASE ASSOCIATION; DISEASE DURATION; DOSE RESPONSE; DRUG MEGADOSE; GENDER; HIGH RISK PATIENT; HUMAN; IMPULSE CONTROL DISORDER; LETTER; LOW DRUG DOSE; MARRIAGE; ONSET AGE; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; UNITED STATES;

DOPAMINE AGONISTS; HUMANS; IMPULSE CONTROL DISORDERS; LEVODOPA;

EID: 79953869322     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.41     Document Type: Letter

References (2)

1. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010; 67(5):589-595.
2. Macphee GJ, Copeland C, Stewart D, Grosset K, Grosset DG. Clinical follow up of pathological gambling in Parkinson's disease in the West Scotland study. Mov Disord. 2009;24(16):2430-2431.